Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress

被引：0
|
作者：
Oh, Do-Youn
Kim, Jin Won
Chon, Hongjae
Lee, Choong-Kun
Kim, Ji-Won
Kang, Beodeul
Choi, Hye Jin
Park, Se Jun
Yoon, Jeesun
Lee, Myung Ah
机构：
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Canc Res Inst,Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[3] CHA Univ, CHA Bundang Med Ctr, Med Oncol, Seongnam, South Korea
[4] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med,Div Med Oncol, Seoul, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
[6] Yonsei Univ, Dept Internal Med, Yonsei Canc Ctr, Coll Med,Div Med Oncol, Seoul, South Korea
[7] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Coll Med,Div Oncol, Seoul, South Korea
[8] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.TPS490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS490
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment
    Yoon, Jeesun
    Lee, Choong-kun
    Kim, Ji-Won
    Kang, Beodeul
    Park, Se Jun
    Kim, Jin Won
    Chon, Hong Jae
    Choi, Hye Jin
    Lee, Myung Ah
    Oh, Do-Youn
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [3] Phase II trial of the HDAC inhibitor, vorinostat, in combination with tamoxifen for patients with advanced breast cancer who have failed prior anti-hormonal therapy
    Lacevic, M.
    Minion, S. E.
    Schmitt, M. L.
    Bicaku, L.
    Marchion, D. C.
    Munster, P. N.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S117 - S117
  • [4] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
  • [5] Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II Trial
    Chung, Moon Jae
    Park, Semi
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    GASTROENTEROLOGY, 2010, 138 (05) : S761 - S761
  • [6] A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)
    Kang, Yoon-Koo
    Ryoo, Baek-Yeol
    Yoon, Shinkyo
    Shen, Lin
    Lee, Jooyun
    Wei, Chenlu
    Zhou, Yu
    Ryu, Min-Hee
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 309 - 318
  • [7] A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)
    Yoon-Koo Kang
    Baek-Yeol Ryoo
    Shinkyo Yoon
    Lin Shen
    Jooyun Lee
    Chenlu Wei
    Yu Zhou
    Min-Hee Ryu
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 309 - 318
  • [8] Phase II study of S-1 in patients with advanced biliary tract cancer
    H Ueno
    T Okusaka
    M Ikeda
    Y Takezako
    C Morizane
    British Journal of Cancer, 2004, 91 : 1769 - 1774
  • [9] Phase II study of S-1 in patients with advanced biliary tract cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1769 - 1774
  • [10] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
12345